crossover_entry
TL3 Regular · Strasbourg, FR
Clinician. Posts general information only, and says so every time.
Joined 13 December 2024 · last posted 12h · groups: clinicians
128 posts, newest first. Showing up to 150.
-
About the Comorbidities category Replied, post #5 · Clinical › Comorbidities · 27 Jul 2026 · 0 likes Interactions between comorbidities: diabetes and kidney disease together change the risk calculation for hypoglycemia and for medication clearance. They are not…
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #52 · Compounds › Secretagogues & GH axis · 20 Jul 2026 · 21 likes CJC-1295 exists in two forms in circulation — with and without the drug affinity complex — and they have very different half-lives. Product descriptions frequently do…
-
Washout with a one-week half-life: the arithmetic — does this still hold? Replied, post #43 · Research Methods › N-of-1 designs · 20 Jul 2026 · 10 likes Reading back through the Washout threads from last year, the same three questions come up every time and only one of them has ever been answered properly. That seems…
-
Revisiting: Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #8 · Compounds › Retatrutide · 20 Jul 2026 · 1 like I have three months of notes on Hepatic effects of glucagon receptor and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly…
-
Second pass at: When your prescriber and the evidence disagree Replied, post #51 · Clinical › Prescriber conversations · 16 Jul 2026 · 5 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation.
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #45 · Practice › Side effects · 12 Jul 2026 · 2 likes The arithmetic on Muscle cramps is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch it.
-
How much context is too much context in a first post? Replied, post #54 · Start Here › How to Ask · 9 Jul 2026 · 25 likes On post #52 — agreed on the reasoning, with one qualification. Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done…
-
An 18-month record including the parts that went badly Replied, post #61 · Outcomes › Progress reports · 6 Jul 2026 · 0 likes Nothing here is medical advice and a progress report is a description of what happened to one person under uncontrolled conditions. If anyone has run this properly I…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #15 · Analytics › HPLC & UHPLC · 6 Jul 2026 · 19 likes Post #12 is the version of this I will quote in future. One addition. Injection volume matters because column overload distorts peak shape, and an overloaded main peak…
-
Follow-up: Reading an interaction checker output critically Replied, post #33 · Practice › Interactions · 6 Jul 2026 · 17 likes Building on post #32 rather than restating it. Alcohol is not contraindicated in the labelling and it does irritate a stomach that is already emptying slowly. There is…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #40 · Compounds › Retatrutide · 5 Jul 2026 · 21 likes One caution on TRIUMPH: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely stated.
-
Review: a draft on reconstitution arithmetic, with objections — one year on Replied, post #36 · Documentation › Doc review · 30 Jun 2026 · 15 likes Post #34 and I disagree about the size of the effect, not about the direction. Check the arithmetic in every worked example by hand. A wrong worked example is worse…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #104 · Outcomes › Body composition · 28 Jun 2026 · 14 likes Post #103 is right about the mechanism and I think understates the practical bit. Precision versus accuracy: the precision you need depends on what question you are…
-
Second pass at: Absence of evidence and evidence of absence Replied, post #31 · Research Methods › Statistics · 27 Jun 2026 · 1 like A definition problem is doing most of the work in this Absence of evidence discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what…
-
Follow-up: Signs of dehydration worth acting on Replied, post #6 · Safety › Adverse events · 26 Jun 2026 · 0 likes Worth separating two things that post #2 runs together. I think the Signs of dehydration worth acting question is answerable and has not been answered, which is a more…
-
Aggregate verification data across the directory, with caveats Replied, post #11 · Sourcing › Independent verification · 24 Jun 2026 · 0 likes Where I part company with post #7, and it is a narrow parting. Repeat testing: if you want to verify the same lot a second time, testing with a different service…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #85 · Compounds › Semaglutide · 24 Jun 2026 · 6 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
Tracking intake honestly when appetite is absent Replied, post #68 · Nutrition & Training › Protein & intake · 21 Jun 2026 · 0 likes Tracking intake is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty minutes…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #48 · Analytics › Impurities & related substances · 16 Jun 2026 · 15 likes Post #45 put the caveat in the right place and I want to underline it. Marking my uncertainty on Endotoxin explicitly. I am confident about the direction, much less…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #21 · Sourcing › Independent verification · 16 Jun 2026 · 14 likes The useful distinction on Interpreting a result is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has…
-
Comparing prices across jurisdictions without misleading yourself Replied, post #83 · Access › Pricing · 15 Jun 2026 · 8 likes Answering the question post #81 raises rather than the one it answers. The site carries no prices, no payment routes and no supplier links beyond the documented…
-
Micro-titration: a disputed topic, argued properly Replied, post #89 · Practice › Dosing & titration · 14 Jun 2026 · 0 likes Two sentences on micro-titration and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is…
-
Request: a per-category review queue Replied, post #27 · Meta › Feature requests · 9 Jun 2026 · 15 likes I read post #25 twice before replying, because I had assumed the opposite. Reading back through the per-category review queue threads from last year, the same three…
-
Prescription portability between countries Replied, post #56 · Access › International · 7 Jun 2026 · 0 likes Post #55 describes the usual case. This is about the unusual one. A definition problem is doing most of the work in this prescription portability between countries…
-
The anatomy of a question that gets answered within an hour Replied, post #66 · Start Here › How to Ask · 4 Jun 2026 · 6 likes A question about somebody else's post should be a reply to that post, not a new topic. A question the post happened to raise should be a new topic linking back to it.…
-
About the Impurities & related substances category Replied, post #6 · Analytics › Impurities & related substances · 29 May 2026 · 4 likes Post #4 and I disagree about the size of the effect, not about the direction. Incomplete deprotection leaves a protecting group attached, raising the mass substantially…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #35 · Analytics › Method validation · 28 May 2026 · 7 likes Linearity: the detector response is proportional to compound concentration across the working range. Demonstrated by running standards at multiple concentrations and…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #44 · Analytics › HPLC & UHPLC · 16 May 2026 · 14 likes I had written a reply contradicting post #40 and deleted it. Here is what survived. Typical suitability criteria are a replicate area relative standard deviation below…
-
What to include when your question involves a chromatogram — one year on Replied, post #2 · Start Here › How to Ask · 9 May 2026 · 2 likes I read the opening post twice before replying, because I had assumed the opposite. Five questions in one post gets you one answer: the easiest one, usually not the one…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #75 · Evidence › Trials · 6 May 2026 · 3 likes I would be cautious about generalising from the Subgroup analyses example above. It is a good example. It is one example.
-
Tracking intake honestly when appetite is absent Replied, post #15 · Nutrition & Training › Protein & intake · 4 May 2026 · 0 likes Post #11 and I disagree about the size of the effect, not about the direction. The question underneath tracking intake is usually "how would I tell?" rather than "what…
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #20 · Pharmacology › Formulation chemistry · 4 May 2026 · 0 likes The reason Solubility limits keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #56 · Clinical › Bloodwork · 3 May 2026 · 0 likes I had written a reply contradicting post #52 and deleted it. Here is what survived. Liver enzyme changes during rapid weight loss are commonly reported and have several…
-
Coming back to: Swirling versus inverting versus leaving it alone Replied, post #10 · Practice › Reconstitution · 25 Apr 2026 · 0 likes Building on post #8 rather than restating it. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #97 · Practice › Dosing & titration · 23 Apr 2026 · 0 likes Post #94 answers the question as asked. The question underneath it is different. Going back down a step is not a failure and the trials allowed it. Several protocols…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #71 · Practice › Side effects · 21 Apr 2026 · 11 likes Taking Dizziness on standing seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and…
-
Fasting versus non-fasting and which tests care Replied, post #15 · Clinical › Bloodwork · 20 Apr 2026 · 3 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #69 · Practice › Administration · 7 Apr 2026 · 3 likes Letting a refrigerated preparation come to room temperature before injecting reduces the sting for most people. It is not a stability requirement, it is a comfort one,…
-
Sample size intuition for a personal experiment — does this still hold? Replied, post #12 · Research Methods › Statistics · 2 Apr 2026 · 18 likes I had written a reply contradicting post #9 and deleted it. Here is what survived. Whatever the answer on Sample size intuition turns out to be, the method for getting…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #93 · Regional › UK & Ireland · 27 Mar 2026 · 23 likes Understood. Thank you for being specific about the limits of it.
-
Second pass at: Identical chromatograms across two different lots Replied, post #82 · Sourcing › Red flags · 21 Mar 2026 · 17 likes Coming back to post #78, because the follow-up matters more than the original answer. Prices well below the rest of the market are a fact rather than a finding. They…
-
Which fields on a certificate actually matter, ranked Replied, post #30 · Analytics › COA interpretation · 20 Mar 2026 · 0 likes I read post #28 twice before replying, because I had assumed the opposite. An itemised related-substances table with retention times says considerably more about the…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #120 · Access › Pricing · 19 Mar 2026 · 15 likes A price well below the rest of the market is a fact rather than a finding, and it is worth noting without concluding from it.
-
Second pass at: Identical chromatograms across two different lots Replied, post #67 · Sourcing › Red flags · 15 Mar 2026 · 1 like Narrowing post #66, because the general version has more than one answer. Where the same certificate image appears with different lot numbers, that is a documentation…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #50 · Practice › Interactions · 14 Mar 2026 · 0 likes Two sentences on anaesthesia and elective surgery and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #29 · Practice › Administration · 6 Mar 2026 · 0 likes The bit of Rotating between abdomen that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #86 · Practice › Storage & stability · 1 Mar 2026 · 3 likes On post #84 — agreed on the reasoning, with one qualification. Dry storage in a freezer is generally more protective than a refrigerator for long periods, provided the…
-
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #44 · Evidence › Trials · 22 Feb 2026 · 0 likes Everything in post #40 holds. The case it does not cover is the one I have. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #33 · Research Methods › Statistics · 16 Feb 2026 · 0 likes Post #29 and I disagree about the size of the effect, not about the direction. Bayesian and frequentist analyses answer different questions and both are legitimate.…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #10 · Analytics › Mass spectrometry · 11 Feb 2026 · 0 likes Post #9 is right about the mechanism and I think understates the practical bit. Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS,…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #126 · Analytics › COA interpretation · 6 Feb 2026 · 23 likes On post #124 — agreed on the reasoning, with one qualification. A document that puts the specification in the result column has told you the release criterion rather…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #42 · Practice › Storage & stability · 28 Jan 2026 · 8 likes Post #40 describes the usual case. This is about the unusual one. The failure mode on storing lyophilised material long term is boring rather than dramatic. It is…
-
Revisiting: Is there a ceiling dose beyond which semaglutide stops adding benefit? Replied, post #3 · Compounds › Semaglutide · 26 Jan 2026 · 0 likes On dose steps: the four-week interval in the pivotal programme was a trial design choice, and slower escalation was not studied. That means the evidence supports not…
-
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #13 · Evidence › Trials · 17 Jan 2026 · 25 likes Reading the supplementary appendix is where most of the real information is, and it is where almost nobody goes. The baseline table alone answers half the…
-
The headache that turns out to be dehydration Replied, post #135 · Nutrition & Training › Hydration & electrolytes · 12 Jan 2026 · 0 likes Where I part company with post #131, and it is a narrow parting. I have been on both sides of the headache argument in this category within eighteen months, which…
-
Constipation management, with a dietitian's contribution Replied, post #17 · Practice › Side effects · 8 Jan 2026 · 18 likes Post #13 describes the usual case. This is about the unusual one. Second-hand on constipation management, so weight it accordingly — someone whose method I trust told…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #4 · Analytics › Mass spectrometry · 7 Jan 2026 · 29 likes Second this, and I would have said it less carefully.
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #31 · Regional › UK & Ireland · 2 Jan 2026 · 24 likes Private prescribing sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
-
A history of disordered eating: proceeding carefully Replied, post #46 · Wellbeing › Mental health · 31 Dec 2025 · 6 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
Specification in the result column: why that is a meaningful error Replied, post #96 · Analytics › COA interpretation · 28 Dec 2025 · 21 likes A document that puts the specification in the result column has told you the release criterion rather than the measurement. Those are different claims and the…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #37 · Practice › Side effects · 27 Dec 2025 · 1 like The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #3 · Pharmacology › Pharmacokinetics · 26 Dec 2025 · 5 likes Area under the curve is the exposure measure that matters for most effects in this class. Peak concentration matters more for tolerability.
-
The decimal-point error, and the habit that catches it Replied, post #94 · Practice › Reconstitution · 17 Dec 2025 · 0 likes Speaking only to decimal-point error as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters — a second dataset Replied, post #12 · Compounds › Tirzepatide · 15 Dec 2025 · 11 likes Confirming post #10 from a second method, which matters more than confirming it from a second person. Categorical response thresholds — the proportion reaching ten,…
-
Robustness: the parameters worth deliberately varying Replied, post #35 · Analytics › Method validation · 2 Dec 2025 · 11 likes Reading rather than answering, but this is the post I would point somebody at.
-
Managing an unplanned gap in supply — what changed since Replied, post #121 · Access › Shortages · 20 Nov 2025 · 0 likes Stockpiling in response to a shortage worsens it, which is true and is a poor argument to make to somebody who has run out.
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #52 · Clinical › Special populations · 16 Nov 2025 · 0 likes Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not enroll many people over 75. Extrapolating to very old people is…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #50 · Wellbeing › Mental health · 14 Nov 2025 · 0 likes Support here is genuine and is not a substitute for care, and saying both is not a contradiction. Noting that I have skin in this question and have tried to discount…
-
[2026 update] What steady state means for the decision to escalate Replied, post #50 · Practice › Dosing & titration · 10 Nov 2025 · 0 likes Seconded. It reads as careful rather than confident, which is the right register.
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #8 · Start Here › Welcome · 2 Nov 2025 · 14 likes Muting is under-used here. A category you mute stops appearing in Latest for you, and you can unmute it in a second. Most long-term members read four or five categories…
-
EMA product information as a primary source Replied, post #9 · Regional › European Union · 27 Oct 2025 · 0 likes Building on post #6 rather than restating it. Nothing here is medical or legal advice, and this subcategory in particular attracts questions where that matters. I would…
-
New subcategory: rationale and scope Replied, post #135 · Meta › Announcements · 27 Oct 2025 · 31 likes Picking up post #133: that is the part I would want checked first. One caution on new subcategory: everything above assumes the underlying documentation is what it…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #79 · Compounds › Tirzepatide · 22 Oct 2025 · 7 likes Coming back to post #75, because the follow-up matters more than the original answer. SURMOUNT-4's randomised withdrawal design is the strongest available evidence…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #93 · Lounge › Off topic · 13 Oct 2025 · 0 likes Community norms: if you want to discuss how the community should work (not moderation decisions, which go in Meta) the Lounge is a place for that casual discussion.
-
Tirzepatide in obstructive sleep apnoea: reading SURMOUNT-OSA Replied, post #7 · Compounds › Tirzepatide · 8 Oct 2025 · 1 like Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
-
What a confidence interval means, from scratch — the long version Replied, post #4 · Research Methods › Statistics · 4 Oct 2025 · 12 likes That is a fair summary of where the discussion has got to.
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #45 · Compounds › Cagrilintide & amylin analogues · 3 Oct 2025 · 10 likes The monoisotopic mass sits near 3749.9 Da, and the same caveat applies as everywhere else: a mass consistent with the proposed structure is a necessary condition and…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #23 · Clinical › Special populations · 17 Sep 2025 · 4 likes Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not enroll many people over 75. Extrapolating to very old people is…
-
EU-wide position versus national implementation Replied, post #30 · Regional › European Union · 31 Aug 2025 · 0 likes This follows post #29 rather than contradicting it. Correcting a stale claim here is more valuable than adding a new one, because the stale claims are what people find…
-
Reading a supplier's product description as a marketing document Replied, post #61 · Compounds › Other compounds · 23 Aug 2025 · 12 likes Adding the measurement that post #60 says would settle it. Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell compounds…
-
When a tidy document is a signal and when it is decoration Replied, post #8 · Analytics › COA interpretation · 11 Aug 2025 · 0 likes Counter-ion form belongs on the document and almost never is. Acetate and trifluoroacetate salts of the same peptide contain different amounts of peptide per milligram.…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #9 · Practice › Storage & stability · 30 Jul 2025 · 5 likes Taking post #8 at face value and following it one step further. Adding a reference point for power cut for eleven hours. Mine is a single case, collected without…
-
What a documentation review can and cannot tell you Replied, post #46 · Sourcing › Independent verification · 24 Jul 2025 · 31 likes I read post #42 twice before replying, because I had assumed the opposite. Verified here means specific lots were independently measured on stated dates by named…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #55 · Data & Tools › Calculators · 18 Jul 2025 · 26 likes The reason titration planner refuses keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is…
-
Trial registration and comparing the protocol with the paper Replied, post #21 · Evidence › Trials · 12 Jul 2025 · 1 like Post #19 and I disagree about the size of the effect, not about the direction. Adding a small correction to the trial registration summary above rather than a…
-
Tracking that stops updating and then resumes Replied, post #8 · marked as the solution · Sourcing › Logistics · 6 Jul 2025 · 7 likes Split shipments reduce single-point risk and increase the number of transits. Which trade is right depends on what you are protecting against. Posted with less…
-
Coming back to: Official shortage notices and what they authorise Replied, post #40 · Access › Shortages · 26 Jun 2025 · 4 likes Shortage status determines what compounding is permitted in some jurisdictions, which links two questions that otherwise seem unrelated. If it helps: the failure mode…
-
Interpreting a composition change that is within the error bars Replied, post #7 · Outcomes › Body composition · 23 Jun 2025 · 10 likes Bone mineral density changes with substantial weight loss are measurable and slow, and are one of the better reasons to have a baseline scan. On balance I think that is…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #28 · Data & Tools › Calculators · 18 Jun 2025 · 0 likes Confirming post #27 from a second method, which matters more than confirming it from a second person. Where I have landed on titration planner refuses, having got it…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #126 · Compounds › Cagrilintide & amylin analogues · 17 Jun 2025 · 9 likes I had written a reply contradicting post #124 and deleted it. Here is what survived. Worth distinguishing the combination product from the two components bought…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #132 · Access › Insurance & coverage · 15 Jun 2025 · 17 likes Everything in post #128 holds. The case it does not cover is the one I have. A peer-to-peer review is available in many systems and is frequently more productive than a…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #69 · Compounds › Tirzepatide · 11 Jun 2025 · 3 likes On post #67 — agreed on the reasoning, with one qualification. Heart rate rises modestly across this class, tirzepatide included. It is consistent, small, and worth…
-
Asking about a compound your prescriber has not heard of Replied, post #52 · Clinical › Prescriber conversations · 30 May 2025 · 0 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #92 · Clinical › Comorbidities · 22 May 2025 · 1 like Where somebody is on several medicines, the interaction question and the comorbidity question are entangled and both belong with a pharmacist. Small point, but it is…
-
System suitability injections: if they failed, the run did not happen Replied, post #2 · Analytics › HPLC & UHPLC · 17 May 2025 · 13 likes That is consistent with mine, for whatever one more account is worth.
-
Anxiety in the first weeks: drug, situation, or both Replied, post #84 · Wellbeing › Mental health · 5 May 2025 · 13 likes Where I part company with post #80, and it is a narrow parting. If you are in crisis, contact a local emergency or crisis service rather than posting. A volunteer forum…
-
Revisiting: German, French and Dutch differences, compared Replied, post #18 · Regional › European Union · 4 May 2025 · 0 likes Narrowing post #17, because the general version has more than one answer. Shortage notifications are published both centrally and nationally and the two do not always…
-
Ipamorelin selectivity claims and where they came from Replied, post #30 · Compounds › Secretagogues & GH axis · 19 Apr 2025 · 0 likes Adding what did not work for me on ipamorelin selectivity claims, since the failures never get written up and they are half the useful information.
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #99 · Compounds › Cagrilintide & amylin analogues · 16 Apr 2025 · 5 likes Building on post #96 rather than restating it. For anyone arriving from searches on "amylin agonist": this subcategory discusses published clinical evidence and what it…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #99 · Compounds › Cagrilintide & amylin analogues · 3 Apr 2025 · 0 likes Nausea appears in the amylin-analogue literature as it does in the incretin literature, and the two are not additive in a simple way when the drugs are combined. The…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #48 · Practice › Reconstitution · 24 Mar 2025 · 0 likes I came in to disagree and I am leaving without a disagreement.
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #99 · Access › International · 14 Mar 2025 · 13 likes Travel with medication: carrying a compound across borders is complicated by legal status. Documenting that it is prescribed and carrying proof reduces (but does not…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #67 · Analytics › COA interpretation · 10 Mar 2025 · 8 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #58 · Pharmacology › Receptor biology · 8 Mar 2025 · 2 likes Post #57 is right about the mechanism and I think understates the practical bit. The strongest argument against my own position on biased agonism, stated as well as I…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #23 · Analytics › COA interpretation · 24 Feb 2025 · 21 likes Post #20 is right about the mechanism and I think understates the practical bit. I disagree with the framing of Counter-ion form above, and I think it is a substantive…
-
Consistent declarations and why they matter more than clever ones Replied, post #49 · Sourcing › Logistics · 18 Feb 2025 · 0 likes Border outcomes are not predictable at the level of an individual parcel. What is predictable is that consistent, accurate declarations correlate with fewer…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #41 · Compounds › Secretagogues & GH axis · 20 Jan 2025 · 31 likes Adding the measurement that post #38 says would settle it. Well-designed human trial: I would want to see the raw numbers rather than the summary before agreeing.…
-
Fixed versus detachable needles: the trade-offs Replied, post #115 · Devices › Syringes & needles · 15 Jan 2025 · 0 likes Coring the stopper is a real phenomenon with repeated entries at the same point and blunt needles. Varying the entry point slightly and using a fresh needle prevents…
-
Second pass at: A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #7 · Devices › Pens & autoinjectors · 5 Jan 2025 · 0 likes The click count on a dialled pen is a mechanical property of that pen and is not a universal unit. Counting clicks across two different devices is not a conversion.…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #16 · Compounds › Secretagogues & GH axis · 4 Jan 2025 · 5 likes That is a fair summary of where the discussion has got to.
-
A supplier that answers analytical questions with restated claims Replied, post #4 · Sourcing › Red flags · 29 Dec 2024 · 7 likes The opening post describes the usual case. This is about the unusual one. One more thing on supplier that took me far too long to see: the two figures people quote are…
-
When to suspect the method rather than the sample Replied, post #57 · Analytics › Method validation · 28 Dec 2024 · 19 likes An independent laboratory's method being different from the supplier's is not a discrepancy. It becomes one only when the results differ by more than both methods'…
-
Promotion criteria, and the one that stops most nominations Replied, post #122 · Documentation › Doc review · 24 Nov 2024 · 2 likes Interdependencies: if updating one page requires updating related pages, posting that connection here helps the maintainers see the scope of work.
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #40 · Compounds › Tirzepatide · 16 Nov 2024 · 22 likes Answering the question post #37 raises rather than the one it answers. Storage and stability: published data on licensed tirzepatide formulations exists and is worth…
-
When "no data" is the complete and final answer Replied, post #15 · Compounds › Other compounds · 5 Nov 2024 · 22 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #12 · Compounds › Other compounds · 1 Nov 2024 · 23 likes Post #10 and I disagree about the size of the effect, not about the direction. If someone has run Research-use-only status properly I would rather read that than my own…
-
A well-designed study with a badly written abstract — does this still hold? Replied, post #2 · Evidence › Study critique · 26 Oct 2024 · 2 likes Building on the opening post rather than restating it. Small methodological point on well-designed study: repeating a measurement is cheap and resolves most of what is…
-
Requesting a page: what makes a good request — what changed since Replied, post #23 · Documentation › Wiki requests · 9 Oct 2024 · 4 likes Post #22 answers the question as asked. The question underneath it is different. Accessibility feedback: if you have trouble accessing or reading a maintained page…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #62 · Practice › Administration · 28 Sep 2024 · 2 likes That is consistent with mine, for whatever one more account is worth.
-
Meeting a protein target on a suppressed appetite — one year on Replied, post #17 · Nutrition & Training › Protein & intake · 18 Sep 2024 · 10 likes Meeting protein targets on suppressed appetite: this is where the practical difficulty lies. Eating more protein when appetite is suppressed is genuinely hard.…
-
Progressive overload when the scale is falling — one year on Replied, post #45 · Nutrition & Training › Resistance training · 11 Sep 2024 · 4 likes Answering the question post #43 raises rather than the one it answers. Nothing here is medical advice and anybody with a relevant condition should have a programme…
-
Melanocortin agonists: mechanism and the documented adverse profile Replied, post #3 · Compounds › Other compounds · 30 Aug 2024 · 0 likes Solubility varies far more across this subcategory than within the incretins. A compound that needs a specific diluent or a specific pH is not being difficult; it has a…
-
Correlation in a self-tracked dataset: what it can support Replied, post #162 · Research Methods › Statistics · 26 Aug 2024 · 0 likes Where an analysis was changed after seeing the data, the honest thing is to report both and say which was pre-specified. Worth checking against a second source before…
-
Chronic kidney disease and the FLOW result Replied, post #35 · Clinical › Comorbidities · 22 Aug 2024 · 18 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #61 · Analytics › COA interpretation · 13 Aug 2024 · 0 likes I read post #59 twice before replying, because I had assumed the opposite. Peptide content and chromatographic purity are separate determinations and a certificate that…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #73 · Evidence › Journal club · 27 Jul 2024 · 30 likes I had written a reply contradicting post #71 and deleted it. Here is what survived. The most common failure mode is spending fifty minutes on the effect size and ten on…
-
Coming back to: Pricing far outside the range, in either direction Replied, post #3 · Sourcing › Red flags · 18 Jul 2024 · 26 likes Practical answer on Pricing far outside the range, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide…
-
Cold packs, phase-change material, and what survives ten days Replied, post #22 · Sourcing › Logistics · 18 Jun 2024 · 0 likes Adding the measurement that post #19 says would settle it. Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain…